DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSivas Numune Hospital
About this trial
This randomized, double-blind clinical trial aims to compare the effectiveness of the Deep Iliacus Plane Block (DIPB) and the Suprainguinal Fascia Iliaca Block (SIFIB) for postoperative pain control in patients undergoing primary total hip arthroplasty. Effective analgesia after hip surgery is essential for early mobilization, reduction of complications, and improved recovery outcomes.
Seventy patients scheduled for elective hip arthroplasty under spinal anesthesia will be randomly assigned to receive either DIPB or SIFIB at the end of surgery. Postoperative pain scores, opioid consumption, motor block, and block-related complications will be evaluated over a 48-hour period.
The study aims to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared to SIFIB, thereby contributing to safer and more comprehensive postoperative pain management in hip surgery patients.
Eligibility criteria
Qualifiers
Patients aged ≥18 years
ASA physical status I-III
Scheduled for elective primary total hip arthroplasty under spinal anesthesia
Ability to understand the study procedures and provide informed consent
Disqualifiers
Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
Infection at the block application site
Hemodynamic instability
Known allergy to local anesthetics
Trial design
Treatments tested in this trial
- Suprainguinal Fascia Iliaca Block
- Deep Iliacus Plane Block
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov